Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection

M Štěrba, O Popelová, A Vávrová… - Antioxidants & redox …, 2013 - liebertpub.com
Abstract Significance: Anthracyclines (doxorubicin, daunorubicin, or epirubicin) rank among
the most effective anticancer drugs, but their clinical usefulness is hampered by the risk of …

Iron and leukemia: new insights for future treatments

F Wang, H Lv, B Zhao, L Zhou, S Wang, J Luo… - Journal of Experimental …, 2019 - Springer
Iron, an indispensable element for life, is involved in all kinds of important physiological
activities. Iron promotes cell growth and proliferation, but it also causes oxidative stress …

[HTML][HTML] An update on the novel and approved drugs for Alzheimer disease

HA Alhazmi, M Albratty - Saudi Pharmaceutical Journal, 2022 - Elsevier
Introduction Given the severity of the condition and the increasing number of patients,
developing effective therapies for Alzheimer's disease has become a significant necessity …

Redox active metal-induced oxidative stress in biological systems

K Jomova, S Baros, M Valko - Transition Metal Chemistry, 2012 - Springer
A number of studies performed on biological systems have shown that redox-active metals
such as iron and copper as well as other transition metals can undergo redox cycling …

Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management

E Nur, BJ Biemond, HM Otten… - American journal of …, 2011 - Wiley Online Library
Sickle cell disease (SCD) is a hemoglobinopathy characterized by hemolytic anemia,
increased susceptibility to infections and vaso‐occlusion leading to a reduced quality of life …

Immunity, inflammation, and oxidative stress in heart failure: emerging molecular targets

KF Ayoub, NVK Pothineni, J Rutland, Z Ding… - … Drugs and Therapy, 2017 - Springer
Purpose Heart failure (HF) remains a major cause of morbidity and mortality worldwide.
Although various therapies developed over the last two decades have shown improved long …

The iron chelator, deferasirox, as a novel strategy for cancer treatment: oral activity against human lung tumor xenografts and molecular mechanism of action

GYL Lui, P Obeidy, SJ Ford, C Tselepis, DM Sharp… - Molecular …, 2013 - ASPET
Deferasirox is an orally effective iron (Fe) chelator currently used for the treatment of iron-
overload disease and has been implemented as an alternative to the gold standard chelator …

Advances in iron chelation: an update

H Heli, S Mirtorabi, K Karimian - Expert opinion on therapeutic …, 2011 - Taylor & Francis
Introduction: Oxidative stress (caused by excess iron) can result in tissue damage, organ
failure and finally death, unless treated by iron chelators. The causative factor in the etiology …

Advances in multi-functional ligands and the need for metal-related pharmacology for the management of Alzheimer disease

A Sharma, V Pachauri, SJS Flora - Frontiers in Pharmacology, 2018 - frontiersin.org
Alzheimer's disease (AD) is the age linked neurodegenerative disorder with no disease
modifying therapy currently available. The available therapy only offers short term …

Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells

A Vavrova, H Jansova, E Mackova, M Machacek… - PLoS …, 2013 - journals.plos.org
Anthracyclines (such as doxorubicin or daunorubicin) are among the most effective
anticancer drugs, but their usefulness is hampered by the risk of irreversible cardiotoxicity …